{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:27:17Z","timestamp":1775737637425,"version":"3.50.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11010-019-03670-0","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T19:04:13Z","timestamp":1575918253000},"page":"89-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Potential therapeutic effects of antagonizing adenosine A2A receptor, curcumin and niacin in rotenone-induced Parkinson\u2019s disease mice model"],"prefix":"10.1007","volume":"465","author":[{"given":"Tarek K.","family":"Motawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nermin A. H.","family":"Sadik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3643-5842","authenticated-orcid":false,"given":"Manal A.","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaa A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagdy K. B.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yomna R.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"3670_CR1","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1212\/WNL.0b013e31823a0ee4","volume":"77","author":"YA Rajabally","year":"2011","unstructured":"Rajabally YA, Martey J (2011) Neuropathy in Parkinson disease: prevalence and determinants. Neurology 77:1947\u20131950","journal-title":"Neurology"},{"key":"3670_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2010.03.004","volume":"211","author":"TN Taylor","year":"2010","unstructured":"Taylor TN, Greene JG, Miller GW (2010) Behavioral phenotyping of mouse models of Parkinson\u2019s disease. Behav Brain Res 211:1\u201310","journal-title":"Behav Brain Res"},{"key":"3670_CR3","first-page":"308","volume":"24","author":"R Betarbet","year":"2002","unstructured":"Betarbet R, Sherer TB, Greenamyre JT (2002) Animal models of Parkinson\u2019s disease. Bio Essays 24:308\u2013318","journal-title":"Bio Essays"},{"key":"3670_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JTM (2009) A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol Dis 34:279\u2013290","journal-title":"Neurobiol Dis"},{"key":"3670_CR5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","volume":"62","author":"DT Dexter","year":"2013","unstructured":"Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132\u2013144","journal-title":"Free Radic Biol Med"},{"key":"3670_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jnc.14829","volume":"151","author":"MP Bordone","year":"2019","unstructured":"Bordone MP, Salman MM, Titus HE, Amini E, Andersen JV, Chakraborti B et al (2019) The energetic brain\u2014a review from students to students. J Neurochem 151:139\u2013165","journal-title":"J Neurochem"},{"key":"3670_CR7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00228-015-1881-4","volume":"71","author":"JAG Crispo","year":"2015","unstructured":"Crispo JAG, Fortin Y, Thibault DP, Emons M, Bjerre LM, Kohen DE, Perez-Lloret S, Mattison D, Willis AW, Krewski D (2015) Trends in inpatient antiparkinson drug use in the USA, 2001\u20132012. Eur J Clin Pharmacol 71:1011\u20131019","journal-title":"Eur J Clin Pharmacol"},{"key":"3670_CR8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fnagi.2018.00237","volume":"10","author":"P Perez-Pardo","year":"2018","unstructured":"Perez-Pardo P, Broersen LM, Kliest T, van Wijk N, Attali A, Garssen J, Kraneveld AD (2018) Additive effects of levodopa and a neurorestorative diet in a mouse model of Parkinson\u2019s disease. Front Aging Neurosci 10:237","journal-title":"Front Aging Neurosci"},{"key":"3670_CR9","doi-asserted-by":"crossref","first-page":"89369","DOI":"10.1155\/2007\/89369","volume":"2007","author":"A Jacob","year":"2007","unstructured":"Jacob A, Wu R, Zhou M, Wang P (2007) Mechanism of the anti-inflammatory effect of curcumin: PPAR-gamma activation. PPAR Res 2007:89369","journal-title":"PPAR Res"},{"key":"3670_CR10","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1021\/jp3034209","volume":"116","author":"LN Zhao","year":"2012","unstructured":"Zhao LN, Chiu SW, Benoit J, Chew LY, Mu Y (2012) The effect of curcumin on the stability of a\u03b2 dimers. J Phys Chem B 116:7428\u20137435","journal-title":"J Phys Chem B"},{"key":"3670_CR11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.redox.2013.09.003","volume":"1","author":"J Trujillo","year":"2013","unstructured":"Trujillo J, Chirino YI, Molina-Jij\u00f3n E, And\u00e9rica-Romero AC, Tapia E, Pedraza-Chaverr\u00ed J (2013) Reno-protective effect of the antioxidant curcumin: recent findings. Redox Biol 1:448\u2013456","journal-title":"Redox Biol"},{"key":"3670_CR12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2010.07.022","volume":"644","author":"KH Reeta","year":"2010","unstructured":"Reeta KH, Mehla J, Gupta YK (2010) Curcumin ameliorates cognitive dysfunction and oxidative damage in phenobarbitone and carbamazepine administered rats. Eur J Pharmacol 644:106\u2013112","journal-title":"Eur J Pharmacol"},{"key":"3670_CR13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijpharm.2011.06.030","volume":"416","author":"YM Tsai","year":"2011","unstructured":"Tsai YM, Chien CF, Lin LC, Tsai TH (2011) Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. Int J Pharm 416:331\u2013338","journal-title":"Int J Pharm"},{"key":"3670_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjmed.2016.07.038","volume":"130","author":"A Garg","year":"2017","unstructured":"Garg A, Sharma A, Krishnamoorthy P, Garg J, Virmani D, Sharma T, Stefanini G, Kostis JB, Mukherjee D, Sikorskaya E (2017) Role of niacin in current clinical practice: a systematic review. Am J Med 130:173\u2013187","journal-title":"Am J Med"},{"key":"3670_CR15","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1194\/jlr.M050955","volume":"55","author":"KR Feingold","year":"2014","unstructured":"Feingold KR, Moser A, Shigenaga JK, Grunfeld C (2014) Inflammation stimulates niacin receptor (GPR109A\/HCA2) expression in adipose tissue and macrophages. J Lipid Res 55:2501\u20132508","journal-title":"J Lipid Res"},{"key":"3670_CR16","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1185\/030079904125004402","volume":"20","author":"MJ Chapman","year":"2004","unstructured":"Chapman MJ (2004) Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid\u2014a position paper developed by the European Consensus Panel on HDL-C. Curr Med Res Opin 20:1253\u20131268","journal-title":"Curr Med Res Opin"},{"key":"3670_CR17","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s12035-016-9765-x","volume":"54","author":"TK Motawi","year":"2017","unstructured":"Motawi TK, Darwish HA, Hamed MA, El-Rigal NS, Aboul Naser AF (2017) A therapeutic insight of niacin and coenzyme Q10 against diabetic encephalopathy in rats. Mol Neurobiol 54:1601\u20131611","journal-title":"Mol Neurobiol"},{"key":"3670_CR18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2014.10.024","volume":"347","author":"C Wakade","year":"2014","unstructured":"Wakade C, Chong R (2014) A novel treatment target for Parkinson\u2019s disease. J Neurol Sci 347:34\u201338","journal-title":"J Neurol Sci"},{"key":"3670_CR19","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1038\/ncomms4944","volume":"5","author":"M Rahman","year":"2014","unstructured":"Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Muller-Fielitz H, Pokorna B, Vollbrandt T, Stolting I, Nadrowitz R, Okun JG, Offermanns S, Schwaninger M (2014) The betahydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun 5:3944","journal-title":"Nat Commun"},{"key":"3670_CR20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.expneurol.2011.09.022","volume":"232","author":"X Ye","year":"2011","unstructured":"Ye X, Chopp M, Cui X, Zacharek A, Cui Y, Yan T, Shehadah A, Roberts C, Liu X, Lu M, Chen J (2011) Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats. Exp Neurol 232:299\u2013308","journal-title":"Exp Neurol"},{"issue":"10","key":"3670_CR21","first-page":"1","volume":"2016","author":"AM Fathalla","year":"2016","unstructured":"Fathalla AM, Soliman AM, Ali MH, Moustafa AA (2016) Adenosine A2A receptor blockade prevents rotenone-induced motor impairment in a rat model of Parkinsonism. Front Behav Neurosci 2016(10):1\u20135","journal-title":"Front Behav Neurosci"},{"key":"3670_CR22","first-page":"1","volume":"3","author":"SA El Shebiney","year":"2014","unstructured":"El Shebiney SA, El-Denshary ES, Abdel-Salam OME, Salem NA, El-Khyat ZA, El Shaffie N, Abdallah DM (2014) Cannabis resin extract in Parkinson\u2019s disease: behavioral, neurochemical, and histological evaluation. Cell Biol Res Ther 3:1","journal-title":"Cell Biol Res Ther"},{"key":"3670_CR23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10787-007-1614-0","volume":"16","author":"A Rajeswari","year":"2008","unstructured":"Rajeswari A, Sabesan M (2008) Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson\u2019s disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 16:96\u201399","journal-title":"Inflammopharmacology"},{"key":"3670_CR24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nbd.2012.01.001","volume":"46","author":"T Yan","year":"2012","unstructured":"Yan T, Chopp M, Ye X, Liu Z, Zacharek A, Cui Y, Roberts C, Buller B, Chen J (2012) Niaspan increases axonal remodeling after stroke in type 1 diabetic rats. Neurobiol Dis 46:157\u2013164","journal-title":"Neurobiol Dis"},{"key":"3670_CR25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbr.2003.12.021","volume":"153","author":"M Alam","year":"2004","unstructured":"Alam M, Schmidt WJ (2004) L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats. Behav Brain Res 153:439\u2013446","journal-title":"Behav Brain Res"},{"key":"3670_CR26","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59259-469-6","volume-title":"Motor activity and movement disorders","author":"P Sanberg","year":"1996","unstructured":"Sanberg P, Martinez R, Shytle R, Cahill D (1996) The catalepsy test: is a standardized method possible? In: Sanberg PR, Ossenkopp KP, Kavaliers M (eds) Motor activity and movement disorders. Humana Press, New York"},{"key":"3670_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2478\/10004-1254-62-2011-2074","volume":"62","author":"WKB Khalil","year":"2011","unstructured":"Khalil WKB, Booles HF (2011) Protective role of selenium against over-expression of cancer-related apoptotic genes induced by o-Cresol in rats. Arh Hig Rad Toksikol 62:121\u2013129","journal-title":"Arh Hig Rad Toksikol"},{"key":"3670_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7897\/2230-8407.041213","volume":"4","author":"SAA Linjawi","year":"2014","unstructured":"Linjawi SAA, Khalil WKB, Salem LM (2014) Detoxified Jatropha curcaskernel meal impact against benzene-induced genetic toxicity in male rats. Int J Pharm 4:57\u201366","journal-title":"Int J Pharm"},{"key":"3670_CR29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fncel.2018.00125","volume":"12","author":"S Cerri","year":"2018","unstructured":"Cerri S, Ghezzi C, Sampieri M, Siani F, Avenali M, Dornini G, Zangaglia R, Minafra B, Blandini F (2018) The\u00a0exosomal\/total\u00a0\u03b1 synuclein\u00a0satio\u00a0in\u00a0plasma\u00a0is\u00a0associated\u00a0with\u00a0glucocerebrosidase\u00a0activity and\u00a0correlates\u00a0with\u00a0measures\u00a0of\u00a0disease\u00a0severity\u00a0in\u00a0PD\u00a0patients. Front Cell Neurosci 12:125","journal-title":"Front Cell Neurosci"},{"key":"3670_CR30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1267\/ahc.09019","volume":"42","author":"G Wen","year":"2009","unstructured":"Wen G, Hui W, Dan C, Xiao-Qiong W, Jian-Bin T, Chang-Qi L (2009) The effects of exercise-induced fatigue on acetylcholinesterase expression and activity at rat neuromuscular junctions. Acta Histochem Cytochem 42:137\u2013142","journal-title":"Acta Histochem Cytochem"},{"key":"3670_CR31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.55782\/ane-2000-1351","volume":"60","author":"J Zagrodzka","year":"2000","unstructured":"Zagrodzka J, Romaniuk A, Wieczorek M, Boguszewski P (2000) Bicuculline administration into ventromedial hypothalamus: effects on fear and regional brain monoamines and GABA concentrations in rats. Acta Neurobiol Exp 60:333\u2013343","journal-title":"Acta Neurobiol Exp"},{"key":"3670_CR32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron MS, Depierre JW, Mannervik B (1979) Level of glutathione, glutathione reductase and glutathone-S-transferase activities in rat lung and liver. Biochem Biophys Act 582:67\u201378","journal-title":"Biochem Biophys Act"},{"key":"3670_CR33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","volume":"99","author":"ED Wills","year":"1966","unstructured":"Wills ED (1966) Mechanism of lipid peroxide formation in animal tissue. Biochem J 99:667\u2013676","journal-title":"Biochem J"},{"key":"3670_CR34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","volume":"186","author":"Y Kono","year":"1978","unstructured":"Kono Y (1978) Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase. Arch Biochem Biophys 186:189\u2013195","journal-title":"Arch Biochem Biophys"},{"key":"3670_CR35","first-page":"117","volume":"18","author":"ME Rice","year":"1957","unstructured":"Rice ME, Shelton E (1957) Comparison of the reduction of two tetrazolium salts with succinoxidase activity of tissue homogenates. J Nat Cancer Inst 18:117\u2013125","journal-title":"J Nat Cancer Inst"},{"key":"3670_CR36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/clinchem\/19.7.766","volume":"19","author":"AL Babson","year":"1973","unstructured":"Babson AL, Babson SR (1973) Kinetic colorimetric measurement of serum lactate dehydrogenase activity. Clin Chem 19:766\u2013769","journal-title":"Clin Chem"},{"key":"3670_CR37","first-page":"1","volume":"7","author":"H Sun","year":"2012","unstructured":"Sun H, Li P, Chen W, Xiong X, Han Y (2012) Angiotensin II and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive rats. PLoS ONE 7:1\u201311","journal-title":"PLoS ONE"},{"key":"3670_CR38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3109\/00016480903352975","volume":"130","author":"X Sun","year":"2010","unstructured":"Sun X, Wang D, Yu H, Hu L (2010) Serial cytokine levels during wound healing in rabbit maxillary sinus mucosa. Acta Otorrinolaringol 130:607\u2013613","journal-title":"Acta Otorrinolaringol"},{"key":"3670_CR39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1749-6632.1989.tb24000.x","volume":"557","author":"G Schreiber","year":"1989","unstructured":"Schreiber G, Tsykin A, Aldred AR, Thomas T, Fung WP, Dickson PW, Cole T, Birch H, De Jong FA, Milland J (1989) The acute phase response in the rodent. Ann N Y Acad Sci 557:61\u201385","journal-title":"Ann N Y Acad Sci"},{"key":"3670_CR40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jicd.12134","volume":"7","author":"AR Pradeep","year":"2016","unstructured":"Pradeep AR, Suke DK, Prasad MV, Singh SP, Martande SS, Nagpal K, Naik SB, Guruprasad CN, Raju AP, Singh P, Siddaya M (2016) Expression of key executioner of apoptosis caspase-3 in periodontal health and disease. J Invest Clin Dent 7:174\u2013197","journal-title":"J Invest Clin Dent"},{"key":"3670_CR41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0167-4889(02)00193-3","volume":"1590","author":"T Lu","year":"2002","unstructured":"Lu T, Xu Y, Mericle MT, Mellgren RL (2002) Participation of the conventional calpains in apoptosis. Biochem Biophys Acta 1590:16\u201326","journal-title":"Biochem Biophys Acta"},{"key":"3670_CR42","first-page":"40","volume-title":"Theory and practice of histological techniques","author":"J Bancroft","year":"1996","unstructured":"Bancroft J, Stevens A (1996) Theory and practice of histological techniques, 4th edn. Churchill Livingstone, London, pp 40\u2013138","edition":"4"},{"key":"3670_CR43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4:160\u2013164","journal-title":"Nat Cell Biol"},{"key":"3670_CR44","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8:1150\u20131157","journal-title":"Lancet Neurol"},{"key":"3670_CR45","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/emmm.201302475","volume":"5","author":"A Ulusoy","year":"2013","unstructured":"Ulusoy A, Rusconi R, Perez-Revuelta BI, Musgrove RE, Helwig M, Winzen-Reichert B, Di Monte DA (2013) Caudo-rostral brain spreading of alpha-synuclein through vagal connections. EMBO Mol Med 5:1051\u20131059","journal-title":"EMBO Mol Med"},{"key":"3670_CR46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","volume":"20","author":"OM El-Agnaf","year":"2006","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Curran MD, Gibson MJ, Court JA, Schlossmacher MG, Allsop D (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson\u2019s disease. FASEB J 20:419\u2013425","journal-title":"FASEB J"},{"key":"3670_CR47","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1212\/WNL.52.8.1673","volume":"52","author":"R Grondin","year":"1999","unstructured":"Grondin R, Bedard PJ, HadjTahar A, Gregoire L, Mori A, Kase H (1999) Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology 52:1673\u20131677","journal-title":"Neurology"},{"key":"3670_CR48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1353-8020(00)00063-8","volume":"7","author":"S Ferre","year":"2001","unstructured":"Ferre S, Popoli P, Gimenez-Llort L, Rimondini R, Muller CE, Stromberg I, \u00d6gren SO, Fuxe K (2001) Adenosine\/dopamine interaction: implications for the treatment of Parkinson\u2019s disease. Parkinsonism Relat Disord 7:235\u2013241","journal-title":"Parkinsonism Relat Disord"},{"key":"3670_CR49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","volume":"50","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, Willett WC (2001) Prospective study of coffee consumption and risk of Parkinson\u2019s disease in men and women. Ann Neurol 50:56\u201363","journal-title":"Ann Neurol"},{"key":"3670_CR50","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/brain\/awh128","volume":"127","author":"F Calon","year":"2004","unstructured":"Calon F, Dridi M, Hornykiewicz O, Be\u00c2dard PJ, Rajput AH, Di Paolo T (2004) Increased adenosine A2A receptors in the brain of Parkinson\u2019s disease patients with dyskinesias. Brain 127:1075\u20131084","journal-title":"Brain"},{"issue":"71","key":"3670_CR51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.22630","volume":"2","author":"A Kachroo","year":"2012","unstructured":"Kachroo A, Schwarzschild MA (2012) Adenosine A2A receptor gene disruption protects in an \u03b1-synuclein model of Parkinson\u2019s disease. Ann Neurol 2(71):278\u2013282","journal-title":"Ann Neurol"},{"key":"3670_CR52","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s40265-013-0066-7","volume":"73","author":"R Dungo","year":"2013","unstructured":"Dungo R, Deeks ED (2013) Istradefylline: first global approval. Drugs 73:875\u2013882","journal-title":"Drugs"},{"key":"3670_CR53","doi-asserted-by":"crossref","first-page":"e0166415","DOI":"10.1371\/journal.pone.0166415","volume":"11","author":"J Lu","year":"2016","unstructured":"Lu J, Cui J, Li X, Wang X, Zhou Y, Yang W, Chen M, Zhao J, Gang Pe (2016) An anti-Parkinson\u2019s disease drug via targeting adenosine A2A receptor enhances amyloid-\u03b2 generation and \u03b3-secretase activity. PLoS ONE 11:e0166415","journal-title":"PLoS ONE"},{"key":"3670_CR54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000354670","volume":"13","author":"Y Compta","year":"2014","unstructured":"Compta Y, Parkkinen L, Kempster P, Selikhova M, Lashley T, Holton JL, Lees AJ, Revesz T (2014) The significance of \u03b1-synuclein, amyloid-\u03b2 and tau pathologies in Parkinson\u2019s disease progression and related dementia. Neurodegener Dis 13:154\u2013156","journal-title":"Neurodegener Dis"},{"key":"3670_CR55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000285511","volume":"7","author":"J Shen","year":"2010","unstructured":"Shen J (2010) Impaired neurotransmitter release in Alzheimer\u2019s and Parkinson\u2019s diseases. Neurodegener Dis 7:80\u201383","journal-title":"Neurodegener Dis"},{"key":"3670_CR56","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/npjparkd.2016.1","volume":"2","author":"S Perez-Lloret","year":"2016","unstructured":"Perez-Lloret S, Barrantes FJ (2016) Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease. NPJ Parkinson\u2019s Dis 2:16001","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"3670_CR57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/JPRLS.S151452","volume":"8","author":"G Muthian","year":"2018","unstructured":"Muthian G, Mackey V, Prasad K, Charlton C (2018) Curcumin and an antioxidant formulation protect C57BL\/6\u00a0J mice from MPTP-induced Parkinson\u2019s disease like changes: potential neuroprotection for neurodegeneration. J. Parkinsonism Restless Legs Synd 8:49\u201359","journal-title":"J. Parkinsonism Restless Legs Synd"},{"key":"3670_CR58","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/NEN.0b013e31816ff780","volume":"67","author":"LJ Martin","year":"2008","unstructured":"Martin LJ (2008) DNA damage and repair: relevance to mechanisms of neurodegeneration. Neuropathol Exp Neurol 67:377\u2013387","journal-title":"Neuropathol Exp Neurol"},{"key":"3670_CR59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-015-0189-z","volume":"3","author":"WM Zawada","year":"2015","unstructured":"Zawada WM, Mrak RE, Biedermann JA, Palmer QD, Gentleman SM, Aboud O, Griffin WST (2015) Loss of angiotensin II receptor expression in dopamine neurons in Parkinson\u2019s disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation. Acta Neuropathol Commun 3:9","journal-title":"Acta Neuropathol Commun"},{"key":"3670_CR60","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.15419\/bmrat.v4i05.169","volume":"4","author":"A Saeed","year":"2017","unstructured":"Saeed A, Shakir L, Khan MA, Ali A, Yousaf M, Zaidi AA (2017) Haloperidol induced Parkinson\u2019s disease mice model and motor-function modulation with Pyridine-3-carboxylic acid. Biomed Res Ther 4:1305\u20131317","journal-title":"Biomed Res Ther"},{"key":"3670_CR61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11515-017-1450-6","volume":"12","author":"MJ Farshbaf","year":"2017","unstructured":"Farshbaf MJ (2017) Succinate dehydrogenase in Parkinson\u2019s disease. Front Biol 12:175\u2013182","journal-title":"Front Biol"},{"key":"3670_CR62","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","volume":"12","author":"MHR Ludtmann","year":"2018","unstructured":"Ludtmann MHR, Angelova PR, Horrocks MH, Choi ML, Rodrigues M, Baev AY, Berezhnov AV, Yao Z, Little D, Banushi B, Al-Menhali AS, Ranasinghe RT, Whiten DR, Yapom R, Dolt KS, Devine MJ, Gissen P, Kunath T, Jaganjac M, Pavlov EV, Klenerman D, Abramov AY, Gandhi S (2018) \u03b1-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson\u2019s disease. Nat Commun 12:2293","journal-title":"Nat Commun"},{"key":"3670_CR63","doi-asserted-by":"crossref","first-page":"20087","DOI":"10.1073\/pnas.1008189107","volume":"107","author":"JM Ross","year":"2010","unstructured":"Ross JM, \u00d6berg J, Bren\u00e9 S, Coppotelli G, Terzioglu M, Pernold K, Goinyg M, Sitnikov R, Kehr J, Trifunovic A, Larsson N, Hoffer BJ, Olson L (2010) High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A\/B ratio. PNAS 107:20087\u201320092","journal-title":"PNAS"},{"key":"3670_CR64","first-page":"78","volume":"50","author":"J Zhou","year":"2018","unstructured":"Zhou J, Liu T, Guo H, Cui H, Li P, Feng D, Hu E, Huang Q, Yang A, Zhou J, Luo J, Tang T, Wang Y (2018) Lactate potentiates angiogenesis and neurogenesis in experimental intracerebral hemorrhage. Exp Mol Med 50:78","journal-title":"Exp Mol Med"},{"issue":"275","key":"3670_CR65","first-page":"260996","volume":"2000","author":"N Jha","year":"2000","unstructured":"Jha N, Jurma O, Lalli G, Liu Y, Pettus EH, Greenamyre JT, Liu RM, Forman HJ, Andersen JK (2000) Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex 1 activity: implications for Parkinson\u2019s disease. J Biol Chem 2000(275):260996","journal-title":"J Biol Chem"},{"key":"3670_CR66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1570159X11311020007","volume":"11","author":"T Jiang","year":"2013","unstructured":"Jiang T, Gao L, Lu J, Zhang YD (2013) ACE2-Ang-(1\u20137)-mas axis in brain: a potential target for prevention and treatment of ischemic stroke. Curr Neuropharmacol 11:209\u2013217","journal-title":"Curr Neuropharmacol"},{"key":"3670_CR67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00429-012-0402-9","volume":"218","author":"P Garrido-Gil","year":"2013","unstructured":"Garrido-Gil P, Valenzuela R, Villar-Cheda B, Lanciego JL, Labandeira-Garcia JL (2013) Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigra. Brain Struct Funct 218:373\u2013388","journal-title":"Brain Struct Funct"},{"key":"3670_CR68","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/emmm.201000080","volume":"2","author":"A Benigni","year":"2010","unstructured":"Benigni A, Cassis P, Remuzzi G (2010) Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2:247\u2013257","journal-title":"EMBO Mol Med"},{"key":"3670_CR69","doi-asserted-by":"crossref","first-page":"e0134118","DOI":"10.1371\/journal.pone.0134118","volume":"10","author":"H Sawada","year":"2015","unstructured":"Sawada H, Oeda T, Umemura A, Tomita S, Kohsaka M, Park K, Yamamoto K, Sugiyama H (2015) Baseline C-reactive protein levels and life prognosis in Parkinson disease. PLoS ONE 10:e0134118","journal-title":"PLoS ONE"},{"key":"3670_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00384","volume-title":"C-reactive protein and risk of Parkinson\u2019s disease: A systematic review and meta-analysis","author":"X Qiu","year":"2019","unstructured":"Qiu X, Xiao Y, Wu J, Gan L, Huang Y, Wang J (2019) C-reactive protein and risk of Parkinson\u2019s disease: A systematic review and meta-analysis. Neurology, Front. https:\/\/doi.org\/10.3389\/fneur.2019.00384"},{"key":"3670_CR71","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/19390211.2016.1275916","volume":"14","author":"YA Khadrawy","year":"2017","unstructured":"Khadrawy YA, Salem AM, El-Shamy KA, Ahmed EK, Fadl NN, Hosny EN (2017) Neuroprotective and therapeutic effect of caffeine on the rat model of Parkinson\u2019s disease induced by rotenone. J Diet Suppl 14:553\u2013572","journal-title":"J Diet Suppl"},{"key":"3670_CR72","doi-asserted-by":"crossref","first-page":"28812","DOI":"10.1074\/jbc.M110.126664","volume":"285","author":"ML Hegde","year":"2010","unstructured":"Hegde ML, Hegde PM, Holthauzen LM, Hazra TK, Rao KS, Mitra S (2010) Specific inhibition of NEIL-initiated repair of oxidized base damage in human genome by copper and iron: potential etiological linkage to neurodegenerative diseases. J Biol Chem 285:28812\u201328825","journal-title":"J Biol Chem"},{"key":"3670_CR73","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12906-017-1922-x","volume":"17","author":"XS Wang","year":"2017","unstructured":"Wang XS, Zhang ZR, Zhang MM, Sun MX, Wang WW, Xie CL (2017) Neuroprotective properties of curcumin intoxin-base animal models of Parkinson\u2019s disease: a systematic experiment literatures review. BMC Comp Alt Med 17:412","journal-title":"BMC Comp Alt Med"},{"key":"3670_CR74","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0169-328X(03)00127-X","volume":"114","author":"JN Picada","year":"2003","unstructured":"Picada JN, Floresa DG, Zettler CG, Marroni NP, Roesler R, Henriques JA (2003) D NA damage in brain cells of mice treated with an oxidized form of apomorphine. Mol Brain Res 114:80\u201385","journal-title":"Mol Brain Res"},{"key":"3670_CR75","first-page":"373","volume":"70","author":"M Sawada","year":"2006","unstructured":"Sawada M, Imamura K, Nagatsu T (2006) Role of cytokines in inflammatory process in Parkinson\u2019s disease. J Neural Transm Suppl 70:373\u2013381","journal-title":"J Neural Transm Suppl"},{"key":"3670_CR76","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.parkreldis.2004.10.013","volume":"11","author":"EC Hirsch","year":"2005","unstructured":"Hirsch EC, Hunot S, Hartmann A (2005) Neuroinflammatory processes in Parkinson\u2019s disease. Parkinsonism Relat Disord 11:S9\u2013S15","journal-title":"Parkinsonism Relat Disord"},{"key":"3670_CR77","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1177\/1352458518791683","volume":"25","author":"R Yang","year":"2019","unstructured":"Yang R, Dunn JF (2019) Multiple sclerosis disease progression: contributions from a hypoxia-inflammation cycle. Mult Scler 25:1715\u20131718","journal-title":"Mult Scler"},{"key":"3670_CR78","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s11064-009-9921-z","volume":"34","author":"KW Hofmann","year":"2009","unstructured":"Hofmann KW, Schuh AFS, Saute J, Townsend R, Fricke D, Leke R, Souza DO, Portela LV, Chaves MLF, Rieder CRM (2009) Interleukin-6 serum levels in patients with Parkinson\u2019s disease. Neurochem Res 34:1401\u20131404","journal-title":"Neurochem Res"},{"key":"3670_CR79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0753-3322(99)80079-1","volume":"53","author":"H Bessler","year":"1999","unstructured":"Bessler H, Djaldetti R, Salman H, Bergman M, Djaldetti M (1999) IL-1b, IL-2, IL-6 and TNF-a production by peripheral blood mononuclear cells from patients with Parkinson\u2019s disease. Biomed Pharmacother 53:141\u2013145","journal-title":"Biomed Pharmacother"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03670-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03670-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T09:46:18Z","timestamp":1722159978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03670-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":79,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["3670"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03670-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"16 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animals care during the experiments were carried out in keeping with agreement of the Medical Ethical Committee, National Research Centre, Egypt (Approval No. 16089) and Ethics Committee of Faculty of Pharmacy, Cairo University, Cairo, Egypt (BC 1839). Basic housing requirements and regular inspection of facilities that mandate the control of pain and suffering during the experiment were conducted. Euthanasia was done rapidly and painlessly to be sure that the animals do not suffer at any stage of the experiment. Getting-rid of the animals after termination was done rapidly by the aid of the Safety and Health Committee at National Research Centre, Dokki, Giza, Egypt.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}